Alpharadin

Type: Product
Name: Alpharadin
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Palliative RT Research in Prostate Cancer: Understanding the Past, Anticipating the Future

We read with interest the comprehensive review by Drs. Boyer, Salama, and Lee in this issue of ONCOLOGY,[1] highlighting the important role radiation therapy (RT) plays in the care of men with advanced-stage prostate cancer. We wish to elaborate on a ... [Published Cancernetwork.com - Apr 17 2014]
First reported Apr 12 2014 - Updated Apr 12 2014 - 1 reports

Singapore the first in Asia-Pacific to offer new treatment for prostate cancer

After six years of battling prostate cancer, the remaining options were looking fairly bleak for the 69-year-old New Zealander. Despite surgery to remove his prostate and hormonal treatment to lower his testosterone level, which can cause prostate cancer ... [Published Asiaone - Apr 12 2014]
First reported Mar 16 2014 - Updated Mar 16 2014 - 1 reports

Global nuclear medicine market: Latest market research published

- Nuclear Medicine Market & Radiopharmaceuticals: Global Trends & Forecast to 2017 - a new market research report on companiesandmarkets.comThe market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. ... [Published PR inside - Mar 16 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Radiopharmaceutical Market (Cancer/Oncology, Cardiac) is worth $5.55 Billion by 2017 - Report by MarketsandMarkets

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopesThe Nuclear Medicine Market & Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, ... [Published PitchEngine - Mar 13 2014]
First reported Jan 25 2014 - Updated Jan 26 2014 - 1 reports

Nuclear Medicine/Radiopharmaceutical Market is Worth $5.55 Billion by...

Nuclear Medicine Market & Radiopharmaceuticals Market report covers competitive landscape and key developments of major players, pipeline analysis, investment opportunities, and regulatory affairs for established players as well as new entrants. The Nuclear ... [Published PRWeb - Jan 25 2014]
First reported Jan 14 2014 - Updated Jan 14 2014 - 1 reports

Bayer HealthCare launches oncology treatment Xofigo in UK

Bayer HealthCare has launched Xofigo (radium - 223 dichloride) solution for injection in the UK to treat adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.The launch follows a positive recommendation ... [Published Pharmaceutical Business Review - Jan 14 2014]
First reported Dec 01 2013 - Updated Dec 01 2013 - 1 reports

Asia-Pacific Nuclear Medicine/Radiopharmaceutical Market Worth $825...

Asia-Pacific Nuclear Medicine/Radiopharmaceutical Market report studies the Asia-Pacific nuclear medicine market over the forecast period of 2012 - 2017. The "Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market & Stable Isotopes [SPECT/PET Radioisotopes ... [Published PRWeb - Dec 01 2013]

Quotes

"It doesn't even affect me the slightest now. I hope that when I get my next scan, it will show that the cancer spread has retreated, at least a little bit" he said
...launch and availability of Xofigo in the UK should be welcomed news for physicians and patients, who have been looking for new treatment options. "With today's announcement, we reinforce our commitment to working closely with physicians, patients and other stakeholders to meet the needs of this community" Hemphill said...
...Nuclear Medicine/Radiopharmaceutical Market report studies the Asia-Pacific nuclear medicine market over the forecast period of 2012 - 2017. The "Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market & Stable Isotopes [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" , analyzes and studies the major market drivers, restraints, and opportunities in Japan, China, India, South Korea, Indonesia, Malaysia, Australia, New...
More From BioPortfolio on "Significant overall survival benefit observed with radium 223 in patients with castration-resistant prostate cancer"

More Content

All (13) | News (11) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Palliative RT Research in Prostate Cancer: Unde... [Published Cancernetwork.com - Apr 17 2014]
Singapore the first in Asia-Pacific to offer ne... [Published Asiaone - Apr 12 2014]
Global nuclear medicine market: Latest market r... [Published PR inside - Mar 16 2014]
Radiopharmaceutical Market (Cancer/Oncology, Ca... [Published PitchEngine - Mar 13 2014]
Nuclear Medicine/Radiopharmaceutical Market is ... [Published PRWeb - Jan 25 2014]
Bayer HealthCare launches oncology treatment Xo... [Published Pharmaceutical Business Review - Jan 14 2014]
European Radiopharmaceuticals & Stable Isotopes... [Published PR Newswire - Jan 09 2014]
2013: The year's biggest Pharmaceutical Technol... [Published Pharmaceutical Technology - Jan 08 2014]
Asia-Pacific Nuclear Medicine/Radiopharmaceutic... [Published PRWeb - Dec 01 2013]
European Nuclear Medicine / Radiopharmaceutical... [Published PRWeb - Sep 17 2013]
North American Nuclear Medicine / Radiopharmace... [Published PRWeb - Sep 16 2013]
World Radiopharmaceuticals Market to Reach USD ... [Published PRWeb - Aug 19 2013]
Significant overall survival benefit observed w... [Published BioPortfolio - Jul 19 2013]
1
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
European Radiopharmaceuticals & Stable Isotopes... [Published PR Newswire - Jan 09 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.